Rare diseases
Investigational molecules
Locations
Lichtenbergstrasse 1, 85748, Germany
Research activity is centred on somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, including inoperable and progressive disease with a focus on progression-free survival and treatment response.
The sponsor also studies aggressive Grade 2 and Grade 3 disease within this tumour group, reflecting a strong therapeutic interest in advanced neuroendocrine oncology.
ITM Solucin GmbH runs clinical trials in conditions such as Gastroenteropancreatic neuroendocrine tumour disease, Lymphoma, Neuroendocrine tumour, Gastrointestinal stromal tumour, among others.
Clinical trials run by this sponsor – those enrolling participants first.
France
AustriaFranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
